Diagnosis of asthma - A new approach

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 6, 2012, Pages 713-717

  Lowhagen O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

asthma; basic mechanisms; dyspnea; hyperresponsiveness; physiology; sports

Indexed keywords

ASTHMA; BREATHING; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHEST TIGHTNESS; CLINICAL FEATURE; COUGHING; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; DYSPNEA; EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYMPTOM; WHEEZING;

ASTHMA; DYSPNEA; HUMANS;

EID: 84861031264     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02821.x     Document Type: Review

References (83)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (update 2010), 2010. Available at www.ginasthma.org. Last acessed date 20 March 2012.
2. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120 (5 Suppl): S94-S138.
3. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP,. International Primary Care Respiratory Group (IPSRG) Guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006; 15: 20-34.
4. British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008; 63 (Suppl 4): iv1-iv121.
5. Chapman KR, Boulet LP, Rea RM, Franssen E,. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008; 31: 320-325.
6. Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H,. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma 2010; 47: 257-262.
7. Vermeire PA, Rabe KF, Soriano JB, Maier WC,. Asthma control and differences in management practices across seven European countries. Respir Med 2002; 96: 142-149.
8. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST,. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 2007; 119: 1454-1461.
9. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 120: 1360-1367.
10. Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA,. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 2005; 42: 529-535.
11. Rabe KF, Vermeire PA, Soriano JB, Maier WC,. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807.
12. Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S,. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001; 8 (Suppl A): 35A-40A.
13. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-47.
14. Luskin AT,. Achieving asthma control: the need for risk assessment. Manag Care 2005; 14 (8 Suppl): 12-15; discussion 25-27.
15. FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR,. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J 2006; 13: 253-259.
16. McIvor RA, Boulet LP, FitzGerald JM, Zimmerman S, Chapman KR,. Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician 2007; 53: 673-677.
17. Holgate S, Bisgaard H, Bjermer L, Haahtela T, Haughney J, Horne R, et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008; 32: 1433-1442.
18. Cypcar D, Busse WW,. Steroid-resistant asthma. J Allergy Clin Immunol 1993; 92: 362-372.
19. Nimmagadda SR, Spahn JD, Leung DY, Szefler SJ,. Steroid-resistant asthma: evaluation and management. Ann Allergy Asthma Immunol 1996; 77: 345-355; quiz 355-356.
20. Kay AB,. Pathology of mild, severe, and fatal asthma. Am J Respir Crit Care Med 1996; 154 (2 Pt 2): S66-S69.
21. Barnes PJ,. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004; 1: 264-268.
22. Adcock IM, Ito K,. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 2004; 4: 257-262.
23. Wenzel S,. Severe asthma in adults. Am J Respir Crit Care Med 2005; 172: 149-160.
24. Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF,. Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 2008; 8: 171-178.
25. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
26. Thomas M, McKinley RK, Freeman E, Foy C,. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ 2001; 322: 1098-1100.
27. Johansson A, Bramerson A, Millqvist E, Nordin S, Bende M,. Prevalence and risk factors for self-reported odour intolerance: the Skovde population-based study. Int Arch Occup Environ Health 2005; 78: 559-564.
28. Johansson A, Millqvist E, Nordin S, Bende M,. Relationship between self-reported odor intolerance and sensitivity to inhaled capsaicin: proposed definition of airway sensory hyperreactivity and estimation of its prevalence. Chest 2006; 129: 1623-1628.
29. Bai J, Peat J, Berry G, Marks G, Woolcock A,. Questionnaire items that predict asthma and other respiratory conditions in adults. Chest 1998; 114: 1343-1348.
30. Ringsberg KC, Bjarneman P, Lowhagen O, Oden A, Toren K,. Differences in trigger factors and symptoms between patients with asthma-like symptoms and patients with asthma: development of a basis for a questionnaire. Respir Med 2002; 96: 305-311.
31. Sistek D, Tschopp JM, Schindler C, Brutsche M, Ackermann-Liebrich U, Perruchoud AP, et al. Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study. Swiss Study on Air Pollution and Lung Diseases in Adults. Eur Respir J 2001; 17: 214-219.
32. Pekkanen J, Pearce N,. Defining asthma in epidemiological studies. Eur Respir J 1999; 14: 951-957.
33. Schwartzstein RM, Simon PM, Weiss JW, Fencl V, Weinberger SE,. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 1989; 139: 1231-1237.
34. Manning HL, Schwartzstein RM,. Respiratory sensations in asthma: physiological and clinical implications. J Asthma 2001; 38: 447-460.
35. Nishino T,. Dyspnoea: underlying mechanisms and treatment. Br J Anaesth 2011; 106: 463-474.
36. Manning HL, Schwartzstein RM,. Pathophysiology of dyspnea. N Engl J Med 1995; 333: 1547-1553.
37. Scano G, Stendardi L, Grazzini M,. Understanding dyspnoea by its language. Eur Respir J 2005; 25: 380-385.
38. Simon PM, Schwartzstein RM, Weiss JW, Lahive K, Fencl V, Teghtsoonian M, et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989; 140: 1021-1027.
39. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE,. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 142: 1009-1014.
40. Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T, et al. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991; 71: 2183-2190.
41. Gandevia SC, Killian KJ, Campbell EJ,. The effect of respiratory muscle fatigue on respiratory sensations. Clin Sci (Lond) 1981; 60: 463-466.
42. Lougheed D, Webb K, O'Donell D,. Breathlessness during induced lung hyperinflation in asthma: the role of the inspiratory threshold load. Am J Respir Crit Care Med 1995; 152: 911-920.
43. Lougheed M, Fissher T, O'Donnell D,. Dynamic hyperinflation during bronchoconstriction in asthma. Implication for symptom perception. Chest 2006; 130: 1072-1081.
44. Binks AP, Moosavi SH, Banzett RB, Schwartzstein RM,. " Tightness" sensation of asthma does not arise from the work of breathing. Am J Respir Crit Care Med 2002; 165: 78-82.
45. Moy ML, Woodrow Weiss J, Sparrow D, Israel E, Schwartzstein RM,. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000; 162 (2 Pt 1): 451-455.
46. Manning HL, Mahler DA,. Pathophysiology of dyspnea. Monaldi Arch Chest Dis 2001; 56: 325-330.
47. Undem BJ, Carr MJ,. Pharmacology of airway afferent nerve activity. Respir Res 2001; 2: 234-244.
48. Killian KJ, Watson R, Otis J, St Amand TA, O'Byrne PM,. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med 2000; 162 (2 Pt 1): 490-496.
49. Taguchi O, Kikuchi Y, Hida W, Iwase N, Okabe S, Chonan T, et al. Prostaglandin E2 inhalation increases the sensation of dyspnea during exercise. Am Rev Respir Dis 1992; 145: 1346-1349.
50. Tetzlaff K, Leplow B, Ten Thoren C, Dahme B,. Perception of dyspnea during histamine- and methacholine-induced bronchoconstriction. Respiration 1999; 66: 427-433.
51. Undem BJ, Carr MJ,. The role of nerves in asthma. Curr Allergy Asthma Rep 2002; 2: 159-165.
52. Banzett RB, Lansing RW, Reid MB, Adams L, Brown R,. 'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989; 76: 53-67.
53. Banzett RB, Lansing RW, Brown R, Topulos GP, Yager D, Steele SM, et al. 'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol 1990; 81: 1-17.
54. Lowhagen O,. [Functional respiratory disorders as significant differential diagnosis in asthma]. Lakartidningen 1989; 86: 57-59. Funktionella andningsbesvar viktig differentialdiagnos vid astma.
55. Ringsberg KC, Lowhagen O, Sivik T,. Psychological differences between asthmatics and patients suffering from an asthma-like condition, functional breathing disorder: a comparison between the two groups concerning personality, psychosocial and somatic parameters. Integr Physiol Behav Sci 1993; 28: 358-367.
56. Millqvist E, Bende M, Lowhagen O,. Sensory hyperreactivity-a possible mechanism underlying cough and asthma-like symptoms. Allergy 1998; 53: 1208-1212.
57. Lowhagen O,. Asthma and asthma-like disorders. Respir Med 1999; 93: 851-855.
58. Grossman P, de Swart JC,. Diagnosis of hyperventilation syndrome on the basis of reported complaints. J Psychosom Res 1984; 28: 97-104.
59. Gardner WN,. The pathophysiology of hyperventilation disorders. Chest 1996; 109: 516-534.
60. Folgering H,. The pathophysiology of hyperventilation syndrome. Monaldi Arch Chest Dis 1999; 54: 365-372.
61. Lowhagen O, Arvidsson M, Bjarneman P, Jorgensen N,. Exercise-induced respiratory symptoms are not always asthma. Respir Med 1999; 93: 734-738.
62. Ternesten-Hasseus E, Johansson EL, Bende M, Millqvist E,. Dyspnea from exercise in cold air is not always asthma. J Asthma 2008; 45: 705-709.
63. Bass C,. Hyperventilation syndrome: a chimera? J Psychosom Res 1997; 42: 421-426.
64. Hornsveld H, Garssen B,. Hyperventilation syndrome: an elegant but scientifically untenable concept. Neth J Med 1997; 50: 13-20.
65. Brightling CE,. Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung 2010; 188 (Suppl 1): S13-S17.
66. Brightling CE,. Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction. Pulm Pharmacol Ther 2011; 24: 324-327.
67. Keeley D, Osman L,. Dysfunctional breathing and asthma. It is important to tell the difference. BMJ 2001; 322: 1075-1076.
68. Thomas M, McKinley RK, Freeman E, Foy C, Prodger P, Price D,. Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax 2003; 58: 110-115.
69. Thomas M, McKinley RK, Freeman E, Foy C, Price D,. The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J 2005; 14: 78-82.
70. Thomas M, Bruton A, Moffat M, Cleland J,. Asthma and psychological dysfunction. Prim Care Respir J 2011; 20: 250-256.
71. Ternesten-Hasseus E, Bende M, Millqvist E,. Increased capsaicin cough sensitivity in patients with multiple chemical sensitivity. J Occup Environ Med 2002; 44: 1012-1017.
72. Holst H, Arendt-Nielsen L, Mosbech H, Vesterhauge S, Elberling J,. The capsaicin cough reflex in patients with symptoms elicited by odorous chemicals. Int J Hyg Environ Health 2010; 213: 66-71.
73. Millqvist E,. Cough provocation with capsaicin is an objective way to test sensory hyperreactivity in patients with asthma-like symptoms. Allergy 2000; 55: 546-550.
74. Johansson A, Lowhagen O, Millqvist E, Bende M,. Capsaicin inhalation test for identification of sensory hyperreactivity. Respir Med 2002; 96: 731-735.
75. Nordin S, Millqvist E, Lowhagen O, Bende M,. A short Chemical Sensitivity Scale for assessment of airway sensory hyperreactivity. Int Arch Occup Environ Health 2004; 77: 249-254.
76. Andersson L, Johansson A, Millqvist E, Nordin S, Bende M,. Prevalence and risk factors for chemical sensitivity and sensory hyperreactivity in teenagers. Int J Hyg Environ Health 2008; 211: 690-697.
77. Johansson A, Millqvist E, Bende M,. Relationship of airway sensory hyperreactivity to asthma and psychiatric morbidity. Ann Allergy Asthma Immunol 2010; 105: 20-23.
78. Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res 2009; 10: 94.
79. McClean PA, Howells JCG, Boyd G,. Use of Nijmegen hyperventilation questionnaire and hyperventilation provocation in a hospital asthma clinic. Am J Respir Crit Care Med 1999; 159: A652.
80. Ternesten-Hasseus E, Lowhagen O, Millqvist E,. Quality of life and capsaicin sensitivity in patients with airway symptoms induced by chemicals and scents: a longitudinal study. Environ Health Perspect 2007; 115: 425-429.
81. Ringsberg KC, Segesten K, Akerlind I,. Walking around in circles-the life situation of patients with asthma-like symptoms but negative asthma tests. Scand J Caring Sci 1997; 11: 103-112.
82. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
83. Ternesten-Hasseus E, Larsson C, Bende M, Millqvist E,. Capsaicin provocation using two different inhalation devices. Respir Med 2008; 102: 1784-1790.